Detalles de la búsqueda
1.
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms.
Circ Res;
131(11): 873-889, 2022 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263780
2.
Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.
Circulation;
143(25): 2454-2470, 2021 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33821665
3.
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
J Immunother Cancer;
11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37907221
4.
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.
J Immunother Cancer;
9(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799399
Resultados
1 -
4
de 4
1
Próxima >
>>